Literature DB >> 21352381

Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma.

Dalal Al-Qahtani1, Sukumaran Anil, Ravindranath Rajendran.   

Abstract

This research is aimed to quantitate and characterize the subtypes of tumour infiltrating lymphocytes (TILs), in particular the presence of FoxP3+ Tregs in different grades of oral squamous cell carcinoma using monospecific antibody staining of formalin-fixed, paraffin-embedded tissue sections. The correlation between tumour grade and the intensity of tumour infiltrating lymphocytes was tried to be tested, to assume a putative linkage between them. Thirty-four cases of histologically proven primary oral squamous cell carcinoma (OSCC) of different grades of differentiation were assorted to groups 1-3. Three-micron sections of tissue were cut and captured on electrically charged slides (Vision BioSystem, Mount Waverley, Australia) and stained using monospecific antibody against FoxP3+ Treg phenotype (dilution 1:40, Mouse monoclone No: 236A/E7, Ab 20034, IgG1; Abcam, Cambridge, UK). Automated protocols were employed for staining and scoring of staining intensity using Bond™ system (Vision BioSystem). Significant difference in staining intensities (Tregs) was noted among the histologic grades of tumour, where well-differentiated OSCC had significantly low expression of FoxP3+ Tregs in comparison with moderately and poorly differentiated tumours. A significant linear correlation was established between tumour grade and the intensity of TILs, where high grade tumours (poor differentiation) were more markedly infiltrated. There was also a significant positive correlation between FoxP3+ Tregs and TILs in cases studied. The correlation of these three variables noted in the study (FoxP3+ Tregs, tumour grade and TILs) and their significance in a meta-analysis may prove useful in targeting patients with high-risk neoplasms for more aggressive treatment protocols and management strategies.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352381     DOI: 10.1111/j.1600-0714.2011.01020.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  11 in total

1.  Oral Squamous Carcinoma Cells Express B7-H1 and B7-DC Receptors in Vivo.

Authors:  Sabine Groeger; H P Howaldt; H Raifer; S Gattenloehner; T Chakraborty; J Meyle
Journal:  Pathol Oncol Res       Date:  2016-08-08       Impact factor: 3.201

Review 2.  T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.

Authors:  Daniele Maggioni; Lorenzo Pignataro; Werner Garavello
Journal:  Oncoimmunology       Date:  2017-05-04       Impact factor: 8.110

Review 3.  The role of transforming growth factor-beta in immune suppression and chronic inflammation of squamous cell carcinomas.

Authors:  Alexander A Strait; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2020-04-17       Impact factor: 4.784

4.  Investigation of immune cell markers in feline oral squamous cell carcinoma.

Authors:  Ellen E Sparger; Brian G Murphy; Farina Mustaffa Kamal; Boaz Arzi; Diane Naydan; Chrisoula T Skouritakis; Darren P Cox; Katherine Skorupski
Journal:  Vet Immunol Immunopathol       Date:  2018-06-13       Impact factor: 2.046

5.  Deciphering the Role of Regulatory CD4 T Cells in Oral and Oropharyngeal Cancer: A Systematic Review.

Authors:  Caoimhín O'Higgins; Frank J Ward; Rasha Abu Eid
Journal:  Front Oncol       Date:  2018-10-15       Impact factor: 6.244

6.  Prognostic Significance of Peripheral T-Cell Subsets in Laryngeal Squamous Cell Carcinoma.

Authors:  Filippo Marchi; Francesco Missale; Fabiola Incandela; Marta Filauro; Francesco Mazzola; Francesco Mora; Alberto Paderno; Giampiero Parrinello; Cesare Piazza; Giorgio Peretti
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-08-28

Review 7.  Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma.

Authors:  Hui-Ching Wang; Leong-Perng Chan; Shih-Feng Cho
Journal:  Front Oncol       Date:  2019-10-15       Impact factor: 6.244

Review 8.  Treg: A Promising Immunotherapeutic Target in Oral Diseases.

Authors:  Yujing Zhang; Jihua Guo; Rong Jia
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

9.  Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer.

Authors:  Dan Dayan; Tuula Salo; Sirpa Salo; Pia Nyberg; Sini Nurmenniemi; Daniela Elena Costea; Marilena Vered
Journal:  Cancer Med       Date:  2012-08-16       Impact factor: 4.452

Review 10.  Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma.

Authors:  Liang Zhong; Yutong Liu; Kai Wang; Zhijing He; Zhaojian Gong; Zhili Zhao; Yaocheng Yang; Xiaofei Gao; Fangjie Li; Hanjiang Wu; Sheng Zhang; Lin Chen
Journal:  BMC Cancer       Date:  2018-09-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.